+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Inhibition of Mycobacterium tuberculosis PknG by non-catalytic rubredoxin domain specific modification reaction of an electrophilic nitro-fatty acid with the Fea S center



Inhibition of Mycobacterium tuberculosis PknG by non-catalytic rubredoxin domain specific modification reaction of an electrophilic nitro-fatty acid with the Fea S center







PknG from Mycobacterium tuberculosis is a Ser/Thr protein kinase that regulates key metabolic processes within the bacterial cell as well as signaling pathways from the infected host cell. This multidomain protein has a conserved canonical kinase domain with N- and C-terminal flanking regions of unclear functional roles. The N-terminus harbors a rubredoxin-like domain (Rbx), a bacterial protein module characterized by an iron ion coordinated by four cysteine residues. Disruption of the Rbx-metal binding site by simultaneous mutations of all the key cysteine residues significantly impairs PknG activity. This encouraged us to evaluate the effect of a nitro-fatty acid (9- and 10-nitro-octadeca-9-cis-enoic acid; OA-NO2) on PknG activity. Fatty acid nitroalkenes are electrophilic species produced during inflammation and metabolism that react with nucleophilic residues of target proteins (i.e., Cys and His), modulating protein functioCn and subcellular distribution in a reversible manner. Here, we show that OA-NO2 inhibits kinase activity by covalently adducting PknG remote from the catalytic domain. Mass spectrometry-based analysis established that cysteines located at Rbx are the specific targets of the nitroalkene. Cys-nitroalkylation is a Michael addition reaction typically reverted by thiols. However, the reversible OA-NO2-mediated nitroalkylation of the kinase results in an irreversible inhibition of PknG. Cys adduction by OA-NO2 induced iron release from the Rbx domain, revealing a new strategy for the specific inhibition of PknG. These results affirm the relevance of the Rbx domain as a target for PknG inhibition and support that electrophilic lipid reactions of Rbx-Cys may represent a new drug strategy for specific PknG inhibition.

(PDF emailed within 1 workday: $29.90)

Accession: 036978433

Download citation: RISBibTeXText


Related references

Inhibition of Mycobacterium tuberculosis PknG by non-catalytic rubredoxin domain specific modification: reaction of an electrophilic nitro-fatty acid with the Fe-S center. Free Radical Biology and Medicine 65: 150-161, 2015

Oxidative Unfolding of the Rubredoxin Domain and the Natively Disordered N-terminal Region Regulate the Catalytic Activity of Mycobacterium tuberculosis Protein Kinase G. Journal of Biological Chemistry 291(53): 27062-27072, 2016

PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis. Plos Pathogens 13(5): E1006399, 2017

Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis. Journal of Clinical Microbiology 36(2): 577-579, 1998

Fatty acid and mycolic acid cleavage product analysis to differentiate Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae and Mycobacterium tuberculosis. Abstracts of the General Meeting of the American Society for Microbiology 97(0): 569, 1997

Selective inhibition of the Mycobacterium tuberculosis complex by p-nitro-α-acetylamino-β-hydroxypropio phenone (NAP) and p-nitrobenzoic acid (PNB) used in 7H11 agar medium. Research in Microbiology 140(5): 419-423, 1989

The effect of the electrophilic fatty acid nitro-oleic acid on TRP channel function in sensory neurons. Nitric Oxide 2018, 2018

Periodic acid-Schiff reaction stains Mycobacterium tuberculosis, Mycobacterium leprae, Mycobacterium ulcerans, Mycobacterium chelonei (abscessus), and Mycobacterium kansasii. Archives of Pathology and Laboratory Medicine 109(8): 701-703, 1985

Domain analysis of fatty acid synthase protein (NP_217040) from Mycobacterium tuberculosis H37Rv--a bioinformatics study. Journal of Biomolecular Structure & Dynamics 24(4): 393-412, 2007

Selective inhibition of the Mycobacterium tuberculosis complex by p-nitro-alpha-acetylamino-beta-hydroxypropio phenone (NAP) and p-nitrobenzoic acid (PNB) used in 7H11 agar medium. Research in Microbiology 140(6): 419-423, 1989

Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs. Antimicrobial Agents and ChemoTherapy 51(7): 2430-2435, 2007

Novel Mycobacterium tuberculosis PknG inhibitors. A computational-experimental study. International Journal of Infectious Diseases 73: 345-346, 2018

Method for reduction of inhibition in a Mycobacterium tuberculosis-specific ligase chain reaction DNA amplification assay. Journal of Clinical Microbiology 36(3): 764-767, 1998

Evaluation of p-nitro benzoic acid (pnb) inhibition test to differentiate Mycobacterium tuberculosis complex from non-tuberculous mycobacteria using microscopic observation of drug susceptibility (MODS) methodology. Indian Journal of Tuberculosis 61(3): 232-235, 2014

Inhibition of pigeon liver fatty acid synthetase by specific modification of lysine residues with 2,4,6-trinitrobenzenesulphonic acid. Journal of Enzyme Inhibition 15(4): 421-427, 2000